Special Issue on Translation of Bioactive Materials from Bench to Clinic

The translation of bioactive materials from basic/applied research to successful clinical applications and commercial products involves multiple phases. Such translation, as well as the safety and efficacy of translated medical products, should be demonstrated by solid scientific evidence. The objectives of this special issue are to feature:

• State-of-the-art research on bioactive materials, with an emphasis on novel materials, processing and evaluation methods to facilitate clinical translation
• Processes, issues and lessons-learned for the translation of bioactive materials
• Regulatory science and evidence-based research for the translation of bioactive materials

Topics Covered:

• Processing, structure and property relationships of novel bioactive materials
• In vitro and in vivo evaluation of bioactive materials
• Clinical investigations with a focus on bioactive materials and their clinical outcomes
• Processes and key factors during the translation of bioactive materials to medical products
• Regulatory science for the translation of bioactive materials
• Evidence-based research on bioactive materials

Important Deadlines:

• Submission deadline: 31 August 2021

Submission Instructions:

Please read the Guide for Authors before submitting. All articles should be submitted online; please select [Bench to Clinic] on submission.

Guest Editors:

• Kai Zhang, Institute of Regulatory Science for Medical Devices, School of Biomedical Engineering, Sichuan University, China. Email: kaizhang@scu.edu.cn
• Tony Mikos, Departments of Bioengineering, Chemical and Biomolecular Engineering, Rice University, US. Email: mikos@rice.edu
• Rui Reis, Dept. of Polymer Engineering, School of Engineering, University of Minho, Portugal. Email: rgreis@i3bs.uminho.pt
• Xingdong Zhang, National Engineering Center for Biomaterials, School of Biomedical Engineering, Sichuan University, China. Email: zhangxd@scu.edu.cn